HENDERSON, NV, October 15, 2025 /24-7PressRelease/ -- Alcanza Clinical Research, a mission-focused investigator site network, announces the opening of its newest facility, Desert Clinical Research, in Henderson, Nevada, located within the Las Vegas Metropolitan Area. The research site expands Alcanza's footprint to the southwestern United States and strengthens its capacity to deliver late-stage clinical trials across diverse therapeutic areas.

Equipped with an on-site laboratory, pharmacy, and FibroScan technology, Desert Clinical Research is designed to optimize patient experience, streamline trial execution, and support a growing number of sponsors and CROs seeking access to experienced investigators and operational excellence in the region.

The site's opening was led by Alcanza CEO Carlos Orantes, emphasizing that the expansion into Henderson, Nevada reinforces the network's mission to extend clinical trial access. "Partnering with Dr. Mavis Matsumoto and Shannon Rodman to launch Desert Clinical Research has made this possible," he shared. "We celebrate opening our doors to the surrounding communities."

To celebrate the milestone, Alcanza will host an open house, inviting patients, community partners, and healthcare providers to explore the new facility.

Date: November 5, 2025
Time: 3:30–6:00 PM
Location: 2780 W. Horizon Ridge Pkwy, Henderson, Nevada 89052

The addition of Desert Research Institute aligns with Alcanza's ongoing commitment to expanding patient access to clinical trials and reducing barriers to participation—particularly in underrepresented communities. The site will operate under the Alcanza brand and leverage the network's proven track record in consistently delivering opportunities and access to patients across the nation through reliability and a commitment to innovation.

About Alcanza Clinical Research

Alcanza Clinical Research is an integrated network of research facilities focused on bringing clinical trial opportunities involving life-changing treatments and vaccines to all patients, especially those from under-represented communities. The network includes 24 dedicated research units and additional integrated specialty clinic sites strategically located throughout the Southeast, Northeast, Midwest, Puerto Rico, and now the Southwest. Alcanza supports studies across all trial phases and major therapeutic areas.

# # #